Summary & Overview
HCPCS C7500: Debridement of Bone with Deep Drug-Delivery Device Insertion
HCPCS Level II code C7500 represents surgical debridement of bone and associated soft tissues (epidermis, dermis, subcutaneous tissue, muscle and/or fascia) for the first 20 square centimeters or less performed with manual preparation and insertion of deep drug-delivery device(s). This code captures combined operative management when debridement and implantation of a subfacial or similarly deep drug-delivery system occur during the same procedure. Nationally, accurate use of this code affects hospital and ambulatory surgery center billing for complex wound and device-based therapies and informs utilization reporting for deep implantable drug-delivery interventions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical scope and service context, an outline of common modifiers that may accompany the procedure, typical sites of service, and guidance on what benchmark and policy elements are considered when evaluating coverage and claims handling for deep debridement with device insertion. The publication also summarizes clinical considerations relevant to procedure reporting and highlights areas where payer policy language and claims adjudication practices commonly intersect with coding choices.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code C7500 describes debridement of bone, including epidermis, dermis, subcutaneous tissue, muscle, and/or fascia when performed, for the first 20 square centimeters or less, with manual preparation and insertion of deep (for example, subfacial) drug-delivery device(s). This procedure represents a combined surgical debridement and implantation workflow for deep drug-delivery systems placed beneath the fascial layer.
Service Type: Surgical debridement with device implantation
Typical Site of Service: Hospital operating room or ambulatory surgery center, and other settings equipped for deep surgical debridement and implantation procedures.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a chronic, non-healing lower extremity wound and evidence of osteomyelitis is scheduled for surgical debridement with placement of a deep, subfacial drug-delivery device to deliver local antibiotic therapy. Preoperative evaluation includes wound culture, imaging (radiograph or MRI) confirming suspected bone involvement, and optimization of medical comorbidities (e.g., diabetes mellitus). In the operating room under regional or general anesthesia, the surgeon performs excisional debridement of necrotic epidermis, dermis, subcutaneous tissue, muscle and bone within a defined 20 square centimeter area. After achieving hemostasis and appropriate wound bed preparation, the provider manually prepares and inserts a deep (e.g., subfacial) drug-delivery device such as an antibiotic-eluting bead chain or catheter-based local delivery system. The device is secured per standard technique and the wound is closed or dressed for delayed closure as clinically indicated. Postoperative workflow includes wound care planning, systemic antibiotic coordination, device-specific monitoring, and documentation of device insertion, debridement dimensions, and operative findings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services | Use when work, time, or complexity substantially exceeds usual for this procedure (document rationale). |